MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Psoriasis: Treatment and Pathogenesis
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,393 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,393 works in the cohort · of 4,299,418page 27 of 48

Labels cover 8 of 2,393 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,393 of 2,393 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Disparities in psoriasis clinical trials: A cross-sectional analysis
Jeffrey Ding, Marissa Joseph, Sahil Chawla, Noelle Yau, Zamzam Khosa, Fajr Khawaja +1 more
2022· article· en· Journal of the American Academy of Dermatology· Immunology and Microbiology
machine prediction:candidate · metaresearchconsensus · none
5
citations
affno abstractRetraction · OpenAlex missed itunlabeled
WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR])
Kim Papp, Alice B. Gottlieb, Luigi Naldi, David M. Pariser, Vincent Ho, Kavitha Goyal +5 more
2015· article· en· Journal of the American Academy of Dermatology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
4
citations
affno abstractunlabeled
Burden of Disease for Psoriasis in Argentina, Brazil, Colombia, and Mexico
Emmanuel Papadimitropoulos, Ricardo Romiti, Josep María Haro, Alan Brnabic, Diana Gómez‐Martín, Livia Firmino Goncalves +1 more
2021· article· en· Value in Health Regional Issues· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
4
citations
afffundno abstractunlabeled
Autoantibodies in psoriatic disease
John Koussiouris, Vinod Chandran
2023· review· en· Advances in clinical chemistry· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
4
citations
affno abstractunlabeled
Epidemiology of Psoriasis In Colombia: A Governmental Database Analysis
Félix Hernández, Yaneth Gil-Rojas, Pieralessandro Lasalvia, F. Leonardi Reyes, M. Papadimitropoulos, Camilo Castañeda‐Cardona +1 more
2017· article· en· Value in Health· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
4
citations
affaboutunlabeled
Cost Comparison of Psoriasis Treatments
Dalia M. Mikhael, Kelly Babcock, J. P. DesGroseilliers
2009· article· en· Journal of Cutaneous Medicine and Surgery· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
Transitioning Between Biologics
Ronald Vender
2019· article· en· SKIN The Journal of Cutaneous Medicine· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
Ixekizumab provides persistent improvements in health‐related quality of life and the sexual impact associated with moderate‐to‐severe genital psoriasis in adult patients during a 52‐week, randomised, placebo‐controlled, phase 3 clinical trial
Caitriona Ryan, Lyn Guenther, Peter Foley, Jamie Weisman, Russel Burge, Gaia Gallo +4 more
2021· letter· en· Journal of the European Academy of Dermatology and Venereology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
4
citations
aboutno affunlabeled
Clinical Characteristics of Cutaneous Pain in Psoriasis
Magdalena Kotewicz, Piotr K. Krajewski, Andrzej Jaworek, Jacek C. Szepietowski
2024· article· en· Journal of Clinical Medicine· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
4
citations

How this was built: Screen · Findings · About